UL Prospector

Antiacne Clinical Trials


International Research Services, Inc. (IRSI)目前只在以下作出標識的區域展示其產品資料:

OTC drugs products should undergo clinical trials of acnegenicity to evaluate the efficacy of products in the treatment of acne lesions or evaluate the acnegenic potential of the products.

The expert's assessment and/or instrumental analysis reveals important statements of support: dermatologically tested, clinically proved, antiacne, minimize the appearance of pores, oil control/reduce skin greasiness/sebum control/for acne-prone skin, helps remove dirt and dead skin cells, pH balancing, hydration, sustainably strengthens skin barrier function/helps to increase skin self-defense, and reduce inflammation.

Our team of experts statistically evaluates all the measures listed above to support OTC drug product manufacturers in claims evidence and to market potentially safe and effective skincare products.


International Research Services, Inc. (IRSI) is a privately held clinical research company founded in 1977 that serves the cosmetic and pharmaceutical industries.

Specializing in dermatological safety and efficacy testing, IRSI is a leader in biophysical instrumental analysis of the effects of test products on human skin conditions. For over 40 years of history, IRSI has become a reference in the development and conduct of clinical tests for products from different markets, such as pharmaceutical, cosmetic, hygiene, food and nutrition. In partnership with Allergisa, a Brazilian company with over 25 years of experience in these segments, the tests are carried out within the strictest standards of safety, which guarantees the credibility of the products that will reach people's homes.




設備/服務 Categories